The Patent Finder

Accelerated Pharma, Inc.

Also on record
Records under this name other than patents Accelerated Pharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 4 of 4 · Back to Accelerated Pharma, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,178,564Use of Picoplatin to Treat Colorectal Cancer
Lapsed on the fee record
Ended May 15, 2020 · Low confidence
Lapsed on the fee recordEnded May 15, 2020Low confidence
US 8,173,686Use of Picoplatin to Treat Colorectal Cancer
Lapsed on the fee record
Ended May 8, 2020 · Low confidence
Lapsed on the fee recordEnded May 8, 2020Low confidence
US 8,168,661Use of Picoplatin to Treat Colorectal Cancer
Lapsed on the fee record
Ended May 1, 2020 · Low confidence
Lapsed on the fee recordEnded May 1, 2020Low confidence
US 8,168,662Use of Picoplatin to Treat Colorectal Cancer
Lapsed on the fee record
Ended May 1, 2020 · Low confidence
Lapsed on the fee recordEnded May 1, 2020Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited